Teknologi stem cell yang menurut informasi di bawah ini dikembangkan Dr. Ilham ABuljadayel termasuk kategori menggunakan * sel dewasa *, artinya tidak memerlukan * pembibitan embryo manusia *; sehingga tidak akan banyak menimbulkan potensi kontroversi etik.
Pada metode yang disebut sebagai * retro-differentiation * yang digunakan Dr. Abuljadayel sejak tahun 1990, stem cell diperoleh dari sel-2 darah putih seseorang ( bisa orag dewasa/anak-2/bayi; tetapi bukan embryo); yang di"kembalikan" ke 'kondisi awal' sebelum sel-2 tersebut mengalami spesialisasi fungsi : stem cell, dengan demikian sel ini akan menjadi 'sel serbaguna' untuk mengobati berbagai jenis jaringan. jika sel-2 darah putih tsb. diambil dari sang pasien, maka tidak akan terjadi penolakan dari tubuh, karena berasal dari individu yang sama. =======( ihm )========================== http://www.arabnews.com/? page=1§ion=0&article=52846&d=14&m=10&y=2004 Saudi Woman Scientist Claims Success in --------------------------------------- Stem Cell Research Staff Writer < foto Dr. Ilham Abuljadayel > MANAMA, 14 October 2004 � An innovative new stem cell technology that could potentially benefit patients of many conditions � including sickle cell anemia � has moved a step closer to becoming a worldwide standard, thanks to the help of investors from the Arab world. Stem cell technology is poised to transform the lives of millions currently suffering from debilitating diseases. The successful completion in India of human proof in principle trials of the innovative process, which could spell relief for those afflicted with anemia, diabetes and other ailments was announced this week by TriStem, a company founded in 1999 by Saudi medical specialist Dr. Ilham Abuljadayel and her husband, Ghazi Dhoot. The treatment, based on more than a decade of research, challenges the basics of cellular biology. It has enormous potential within the Arab world where there is an unusually high incidence of anemia and diabetes. Although the path from discovery to distribution of new medical technology is a long and expensive one, the success of Dr. Abuljadayel's recent proof of principle trials in India has been a crucial part of the building blocks needed to prove that the process is safe and effective. The pioneering technique, which was discovered by Dr. Abuljadayel in 1990, uses blood from the patient, which she converts back to its original, prespecialized state � known as a stem cell. The technique, retro-differentiation, works with the patient's white-blood cells creating a supply of stem cells, which can be grown into any number of different cell types to treat many complex and previously untreatable conditions. Because the patient becomes his own donor, there is no risk of rejection by the immune system. This process has been patented worldwide since 1994. "Stem cell research is nothing new," explains Dr. Abuljadayel. "Scientists worldwide have been exploring all aspects of these `blank slate' cells for years. The reason for the widespread interest in them is that they are capable of growing into any type of adult cell. "However, the topic of stem cell research creates controversy throughout the world due to the source of the cells � aborted fetuses or placental tissue. But this controversy may end soon with this new technology," she added. ------------------------ Yahoo! Groups Sponsor --------------------~--> What would our lives be like without music, dance, and theater? Donate or volunteer in the arts today at Network for Good! http://us.click.yahoo.com/MCfFmA/SOnJAA/E2hLAA/BRUplB/TM --------------------------------------------------------------------~-> *************************************************************************** Berdikusi dg Santun & Elegan, dg Semangat Persahabatan. Menuju Indonesia yg Lebih Baik, in Commonality & Shared Destiny. www.ppi-india.org *************************************************************************** __________________________________________________________________________ Mohon Perhatian: 1. Harap tdk. memposting/reply yg menyinggung SARA (kecuali sbg otokritik) 2. Pesan yg akan direply harap dihapus, kecuali yg akan dikomentari. 3. Lihat arsip sebelumnya, www.ppi-india.da.ru; 4. Satu email perhari: [EMAIL PROTECTED] 5. No-email/web only: [EMAIL PROTECTED] 6. kembali menerima email: [EMAIL PROTECTED] Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/ppiindia/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
